Sumatriptan Injection, Solution
Product Images NDC 51407-673

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 51407-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-673-01 (Sumatriptan Injector Label 6 mg0.5 mL)

This text provides details about Sumatriptan Injection USP, a medication delivered through an autoinjector system for subcutaneous injections. Each autoinjector contains 0.5 mL of solution with 8.4 mg of sumatriptan succinate (equivalent to 6 mg of sumatriptan) and 3.5 mg of sodium chloride. The solution has a pH of approximately 4.2 to 5.3 and an osmolality of 270-330 mOsmol. It is sterile, nonpyrogenic, and should be stored between 2° and 30°C (36° and 86°F) while protected from light. This product is marketed by GSMS, Incorporated, in Camarillo, CA, USA, and is a product of Spain.*

FDA Label Image

51407-673-02 (Sumatriptan Injector Carton 6 mg0.5 mL)

This text contains instructions for using a disposable sumatriptan autoinjector system, including details on how to prepare and perform the injection. It provides step-by-step guidance on assembling the autoinjector, applying it to the skin, and monitoring the injection process through a medicine window. Additionally, the text includes essential information on the contents of the autoinjector, storage conditions, and warnings about not using the product if the tamper-evident seal is broken or missing.*

FDA Label Image

Sumatriptan-structure (7b0603f0 Ed39 460b 9d7b F19b95006024 01)

FDA Label Image

Device Image (7b0603f0 Ed39 460b 9d7b F19b95006024 02)

FDA Label Image

Image Description (7b0603f0 Ed39 460b 9d7b F19b95006024 03)

This is a guide for using an autoinjector with a gray cap. It instructs users to remove the cap before the autoinjector will work. Additionally, it advises using a transparent window to check the liquid clarity and pressing the blue injection button firmly to start the injection.*

FDA Label Image

Figure A (7b0603f0 Ed39 460b 9d7b F19b95006024 04)

Not available.*

FDA Label Image

Figure B (7b0603f0 Ed39 460b 9d7b F19b95006024 05)

This is not-available.*

FDA Label Image

Figure C (7b0603f0 Ed39 460b 9d7b F19b95006024 06)

After Injection of medication, the Blue Plunger Rod fills the window on the device. This is shown in Figure C.*

FDA Label Image

Figure D (7b0603f0 Ed39 460b 9d7b F19b95006024 07)

FDA Label Image

Figure E (7b0603f0 Ed39 460b 9d7b F19b95006024 08)

FDA Label Image

Figure F (7b0603f0 Ed39 460b 9d7b F19b95006024 09)

FDA Label Image

Figure G (7b0603f0 Ed39 460b 9d7b F19b95006024 10)

FDA Label Image

Figure H (7b0603f0 Ed39 460b 9d7b F19b95006024 11)

This is a description of an image showing a blue plunger moving down to fill medicine flow after injection.*

FDA Label Image

Figure I (7b0603f0 Ed39 460b 9d7b F19b95006024 12)

FDA Label Image

Figure J (7b0603f0 Ed39 460b 9d7b F19b95006024 13)

FDA Label Image

Figure K (7b0603f0 Ed39 460b 9d7b F19b95006024 14)

FDA Label Image

Time To Relief Of Cluster Headache From Time Of Injectiona (7b0603f0 Ed39 460b 9d7b F19b95006024 17)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.